Vantage Investment Partners’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-166,031
Closed -$6.77M 75
2022
Q1
$6.77M Sell
166,031
-135,259
-45% -$5.81M 0.34% 56
2021
Q4
$14.4M Sell
301,290
-50,504
-14% -$2.27M 0.74% 22
2021
Q3
$14.6M Sell
351,794
-21,617
-6% -$861K 0.76% 22
2021
Q2
$16.9M Buy
373,411
+31,056
+9% +$1.45M 0.81% 24
2021
Q1
$15.1M Buy
342,355
+39,013
+13% +$1.47M 0.74% 27
2020
Q4
$10.5M Buy
+303,342
New +$8.55M 0.61% 33

Other funds holding ADNT

Vantage Investment Partners's ADNT Position: Q2 2022 in Review

Vantage Investment Partners sold out of Adient (ADNT) in Q2 2022, closing a stake of 166,031 shares — an estimated $6.77M sold.

Vantage Investment Partners first reported a position in ADNT in Q4 2020 and held it in 6 quarters. The position peaked at $16.9M in Q2 2021. 258 funds tracked by Wall St. Rank hold ADNT as of Q2 2022.

  • Vantage Investment Partners reported no remaining Adient position as of Q2 2022 after selling out during the quarter.
  • Vantage Investment Partners sold 166,031 Adient shares in Q2 2022, an estimated $6.77M.
  • Vantage Investment Partners first reported a position in Adient in Q4 2020 and held it in 6 quarters.
  • Vantage Investment Partners's Adient position peaked at $16.9M in Q2 2021.
  • 258 funds tracked by Wall St. Rank held Adient as of Q2 2022.

Based on Vantage Investment Partners's 13F filing for Q2 2022, filed 28 Jul 2022.